Shandong Key Laboratory in University of Functional Bioresource Utilization, College of Life Science, Dezhou University , Dezhou City, Shandong Province, PR. China.
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing City, PR. China.
Cell Cycle. 2020 Oct;19(19):2486-2495. doi: 10.1080/15384101.2020.1807666. Epub 2020 Aug 23.
Cervical cancer is a female cancer with the second highest motility over the world. It is urgent to find new therapeutic methods based on long-coding RNAs and microRNAs. UCA1 was proved to be related with many human cancer types, but limited researches have been performed for the inner associations between UCA1 and cervical cancer. Eighty females who were undergoing surgeries were recruited for study in our research. We took the cervical cancer tissues and cells from them. Massive experiments and analysis were conducted to investigate the gene expressions and protein expressions about UCA1, KIF20A, and miR-204 in normal cells and cancer cells. The techniques contain real-time PCR, migration/invasion assay, western blot, in vivo experiments, and so on.We found that UCA1 expression was greatly up-regulated in cervical cancer tissues and cell lines. Our in vitro assays revealed that the suppressing of UCA1 could reduce cervical cancer cells proliferation, migration, and invasion. In addition, we found that lncRNA UCA1 could sponge miR-204 and promote the proliferation and invasion of cervical cancer cells via the up-regulating of KIF20A expression. As a result, the inhibiting of UCA1 could lower cervical cancer (CC) cells growth rate in vivo.Our results identified that UCA1 could serve as an oncogene in cervical cancer cell progression through the modulating of miR-204/KIF20A axis. It gives novel insights to the searching of novel therapeutic methods for cervical cancer.
宫颈癌是全球女性第二大高发癌症,基于长链非编码 RNA 和 microRNA 寻找新的治疗方法迫在眉睫。UCA1 已被证明与许多人类癌症类型有关,但对 UCA1 与宫颈癌之间的内在联系的研究还很有限。本研究招募了 80 名正在接受手术的女性作为研究对象。我们从她们的宫颈组织和细胞中提取了大量的实验和分析,以研究正常细胞和癌细胞中 UCA1、KIF20A 和 miR-204 的基因表达和蛋白表达。技术包括实时 PCR、迁移/侵袭试验、western blot、体内实验等。我们发现 UCA1 在宫颈癌组织和细胞系中表达明显上调。我们的体外试验表明,抑制 UCA1 可以降低宫颈癌细胞的增殖、迁移和侵袭。此外,我们发现 lncRNA UCA1 可以通过上调 KIF20A 的表达来吸附 miR-204,促进宫颈癌的增殖和侵袭。结果表明,抑制 UCA1 可以降低体内宫颈癌(CC)细胞的生长速度。我们的研究结果表明,UCA1 可以通过调节 miR-204/KIF20A 轴在宫颈癌细胞的进展中发挥癌基因的作用。为宫颈癌的新型治疗方法的探索提供了新的思路。